With growth in percutaneous fixes for the valve, surgeons at STS 2025 called for innovation, team-based care, and more data.
19 天
Medpage Today on MSNHeart Surgeons Wary of Being 'Left Behind' in Tricuspid InnovationAt the Society of Thoracic Surgeons (STS) annual meeting, it was standing room only at a session dedicated to why the tricuspid valve should no longer be considered the "forgotten ...
Two patients at MedStar Union Memorial Hospital receive recently FDA-approved Evoque Tricuspid Valve Replacements for severe tricuspid regurgitation. "These groundbreaking procedures represent a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果